CTLA4 and neoplasm: In addition, studies have illustrated that CD4+ T‐cell ICOS expression increases in peripheral blood and tumor tissues of patients treated with anti‐CTLA4 for bladder cancer,54 breast cancer,55 and non‐small cell lung cancer.56